Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Curr Opin Hematol. 2018 Nov;25(6):446-451. doi: 10.1097/MOH.0000000000000463.
Herein, we seek to describe the current and future role of ex-vivo expansion of cord blood hematopoietic stem cells.
As this field is only in its infancy, there have been many challenges identified. Decreased number of stem cells contained in a cord blood unit and early differentiation of stem cells once expanded have been two overarching challenges faced by the field. Many recent techniques have focused on the properties of the microenvironment and targetable cellular pathways as novel approaches to circumvent these challenges.
Novel discoveries have led to the development of approaches that will increase hematopoietic stem cell yield and will improve engraftment in patients receiving cord blood hematopoietic stem cell transplantation. As a result, patients receiving cord blood hematopoietic stem cell transplantationcontinue to have improved outcomes.
本文旨在描述脐带血造血干细胞体外扩增的现状和未来作用。
由于该领域尚处于起步阶段,已经确定了许多挑战。脐带血单位中干细胞数量减少以及干细胞扩增后早期分化是该领域面临的两个主要挑战。许多最近的技术都集中在微环境的特性和可靶向的细胞途径上,作为解决这些挑战的新方法。
新发现导致了能够提高造血干细胞产量并改善接受脐带血造血干细胞移植患者植入的方法的发展。因此,接受脐带血造血干细胞移植的患者的预后继续得到改善。